Business Context and Reporting Period
Company: Deckers Outdoor Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1998
Business Overview: The Company designs, markets, and distributes outdoor footwear under the Teva(R), Simple(R), and Ugg(R) brands. During the period, the Company closed its last remaining owned manufacturing facility in Mexico, shifting entirely to purchasing finished goods from unrelated suppliers.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1998 | Nine Months Ended Sep 30, 1998 |
|---|---|---|
| Net Sales | $13,558,000 | $76,877,000 |
| Gross Profit | $1,307,000 | $27,766,000 |
| Gross Margin % | 9.6% | 36.1% |
| Net Earnings (Loss) | $(5,133,000) | $(1,974,000) |
| EPS (Basic/Diluted) | $(0.60) | $(0.23) |
| Cash from Operations (9mo) | $5,349,000 | |
| Cash and Equivalents (Sep 30, 1998) | $3,830,000 | |
| Working Capital (Sep 30, 1998) | $28,435,000 | |
| Debt (Bank Credit Facility) | $8,470,000 (borrowed) + $9,889,000 (letters of credit) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 34.8% in the third quarter and 7.7% for the nine-month period compared to 1997. The Simple(R) line saw a 44.5% drop in Q3 sales due to declining demand and competition. Teva(R) sales were impacted by a product recall.
- Margin Compression: Gross margin collapsed to 9.6% in Q3 from 35.2% in the prior year. This was driven by approximately $2.5 million in inventory write-downs (Simple(R) excess inventory and Teva(R) raw materials) and a $460,000 loss from a product recall.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased 45.2% in Q3, rising to 69.1% of net sales. Increases were due to higher advertising/marketing spend, bad debt expense, and severance costs from the Mexican factory closure.
- Profitability: The Company reported a net loss of $5.1 million for the quarter and $2.0 million for the nine-month period, contrasting with net earnings of $468,000 and $4.0 million, respectively, in the prior year periods.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Sales Expectations: Management expects Teva(R) and Ugg(R) sales in Q4 1998 to exceed Q4 1997 levels, aided by an early delivery program. Simple(R) sales are expected to remain lower than the prior year.
- Liquidity: The Company obtained waivers for covenant non-compliance (tangible net worth and EBITDA) from its bank. On November 20, 1998, the credit facility was amended to increase maximum availability to $40 million through May 1999, though interest rates were increased.
- Shareholder Rights: On October 9, 1998, the Company adopted a shareholder rights plan ("poison pill") to protect against unsolicited acquisition attempts.
Risks and Contingencies
- Legal Proceedings: A 1995 lawsuit alleges trade secret infringement seeking $15 million in damages; a motion for summary judgment is pending. A new October 1998 lawsuit alleges breach of contract regarding the sale of Trukke Winter Sports Products.
- Trade Duties: European anti-dumping duties (49.2%) may apply to certain Teva(R) styles imported from China/Indonesia, potentially impacting future profitability or requiring sourcing changes.
- License Expiration: The Teva(R) license expires August 31, 2001. Negotiations for renewal are ongoing; failure to renew would materially impact operations.
- Year 2000 Compliance: The Company is in the conversion phase for enterprise systems, with estimated compliance costs exceeding $500,000. Risks include supplier and customer non-compliance.
Investor Verification Checklist
- Covenant Compliance: Verify the status of the amended credit facility covenants and the Company's ability to maintain the required tangible net worth and EBITDA ratios.
- Inventory Valuation: Assess the adequacy of remaining inventory reserves given the significant write-downs on Simple(R) and Teva(R) lines.
- Product Recall Impact: Monitor the final costs associated with the Teva(R) infant sandal recall and any potential liability from the independent factory.
- Legal Exposure: Track the progress of the 1995 trade secret litigation and the new Trukke contract dispute.
- Year 2000 Readiness: Confirm the timeline for completing system conversions and the readiness of key suppliers in the Far East.